Page 1 of Clinical Trials for Drug Linagliptin pioglitazone 30 mg, 4 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by 54 Week Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes
Last Updated: April 4, 2012
Condition(s): Diabetes Mellitus, Type 2
2
Completed
Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
3
Completed
Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
4
Completed
Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components
Last Updated: October 19, 2011
Condition(s): Healthy

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Linagliptin+pioglitazone+30+mg

Page 1 of Clinical Trials for Drug Linagliptin pioglitazone 30 mg, 4 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About